通过向Sortase A发现新型抗Staphylococcus aureus药剂:虚拟查和实验验证的组合
Kang Liu1, Jiangbo Tong1, Xu Liu2
1College of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Pharmaceuticals (Basel, Switzerland)
|January 23, 2024
概括
研究人员将特尔米沙坦确定为对抗黄金葡萄球菌 (S. aureus) 感染的有希望的候选药物. 这种新的方法针对SrtA酶,减少细菌的粘附和侵入,而不会损害生长.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 金黄色葡萄球菌 (S. aureus) 是一种高度致病的细菌,通常被称为"超级细菌",具有重大健康风险.
- 抗生素耐药性的增加需要针对S. aureus的新型治疗策略.
- 排列酶A (SrtA) 是一种转酶,对黄金色杆菌粘附至关重要,是抗菌药物开发的关键标.
研究的目的:
- 为了确定能够抑制S. aureus Sortase A (SrtA) 的新型候选药物.
- 评估潜在的抑制剂在减少细菌毒性而不影响生长中的有效性.
主要方法:
- 利用虚拟选与实验验证相结合,选一个药物库.
- 雇员对接绑定能量和功能站点占用分析以识别被击中化合物.
- 进行了稳定性分析,并评估了与疏水口袋和键形成的结合亲和力.
主要成果:
- 确定了纳尔德美丁,特尔米沙坦和阿齐沙坦作为潜在的SrtA抑制剂.
- 泰尔米沙坦表现出最高的结合能,与SrtA形成稳定的键.
- 证明已识别的化合物降低S. aureus粘附和侵袭效率,而不会对细菌生长产生重大影响.
结论:
- 泰尔米沙坦被确定为抑制S. aureus SrtA的最有前途的候选人.
- 向SrtA提供了一种可行的策略,通过减少毒性来对抗金黄色细菌感染.
- 这项研究突出了解决超级细菌威胁的新治疗途径.
更多相关视频
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
17.7K
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
2.8K
相关概念视频
Antibiotic Selection
Overview
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
